Integrated Radiology, Pathology, and Pharmacy Program to Accelerate Access to Osimertinib.
Ibiayi Dagogo-Jack,Amanda Manoogian, Nicholas Jessop,N Zeke Georgantas,Florian J Fintelmann,Alexander Farahani,Subba R Digumarthy,Melissa C Price,Erik E Folch,Colleen M Keyes,Andrew Do,Jennifer L Peterson,Mari Mino-Kenudson,Martha Pitman,Miguel Rivera,Valentina Nardi,Dora Dias-Santagata,Long P Le,Anthony John Iafrate,Rebecca S Heist,Lauren R Ritterhouse,Jochen K Lennerz JCO oncology practice（2023）
摘要
A workflow involving radiology, pathology, pharmacy, and oncology reduced time between biopsy and osimertinib.
更多查看译文
AI 理解论文
溯源树
样例
